Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

Abstract

Temozolomide in the schedule used has as good activity in chemotherapy-naive metastatic melanoma as the other most active agents currently in use. Further studies of the drug on its own and in combination with other agents is recommended.